Annual Retained Earnings
-$1.02 B
-$113.87 M-12.52%
31 December 2023
Summary:
Adaptimmune Therapeutics annual retained earnings is currently -$1.02 billion, with the most recent change of -$113.87 million (-12.52%) on 31 December 2023. During the last 3 years, it has fallen by -$437.42 million (-74.68%). ADAP annual retained earnings is now -10490.32% below its all-time high of -$9.66 million, reached on 30 June 2012.ADAP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.02 B
-$17.62 M-1.76%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly retained earnings is currently -$1.02 billion, with the most recent change of -$17.62 million (-1.76%) on 30 September 2024. Over the past year, it has dropped by -$44.52 million (-4.56%). ADAP quarterly retained earnings is now -3060.79% below its all-time high of -$32.26 million, reached on 30 June 2014.ADAP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.5% | -4.6% |
| 3 y3 years | -74.7% | -44.6% |
| 5 y5 years | -221.3% | -139.2% |
ADAP Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.7% | at low | -44.6% | +4.8% |
| 5 y | 5 years | -221.3% | at low | -139.2% | +4.8% |
| alltime | all time | <-9999.0% | at low | -3060.8% | +4.8% |
Adaptimmune Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.02 B(+1.8%) |
| June 2024 | - | -$1.00 B(-6.5%) |
| Mar 2024 | - | -$1.07 B(+4.7%) |
| Dec 2023 | -$1.02 B(+12.5%) | -$1.02 B(+4.9%) |
| Sept 2023 | - | -$975.26 M(+4.9%) |
| June 2023 | - | -$929.65 M(+2.4%) |
| Mar 2023 | - | -$908.27 M(-0.1%) |
| Dec 2022 | -$909.30 M(+22.2%) | -$909.30 M(+3.3%) |
| Sept 2022 | - | -$880.05 M(+4.9%) |
| June 2022 | - | -$838.63 M(+5.6%) |
| Mar 2022 | - | -$794.11 M(+6.8%) |
| Dec 2021 | -$743.85 M(+27.0%) | -$743.85 M(+5.5%) |
| Sept 2021 | - | -$704.99 M(+6.4%) |
| June 2021 | - | -$662.59 M(+6.3%) |
| Mar 2021 | - | -$623.52 M(+6.4%) |
| Dec 2020 | -$585.76 M(+28.5%) | -$585.76 M(+6.7%) |
| Sept 2020 | - | -$549.14 M(+6.9%) |
| June 2020 | - | -$513.71 M(+6.2%) |
| Mar 2020 | - | -$483.83 M(+6.2%) |
| Dec 2019 | -$455.66 M | -$455.66 M(+6.9%) |
| Sept 2019 | - | -$426.30 M(+10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | -$387.00 M(+11.9%) |
| Mar 2019 | - | -$345.91 M(+8.6%) |
| Dec 2018 | -$318.50 M(+37.5%) | -$318.50 M(+12.8%) |
| Sept 2018 | - | -$282.33 M(-1.8%) |
| June 2018 | - | -$287.57 M(+17.8%) |
| Mar 2018 | - | -$244.06 M(+5.4%) |
| Dec 2017 | -$231.63 M(+43.4%) | -$231.63 M(+13.3%) |
| Sept 2017 | - | -$204.37 M(+0.4%) |
| June 2017 | - | -$203.49 M(+11.0%) |
| Mar 2017 | - | -$183.27 M(+13.5%) |
| Dec 2016 | -$161.49 M(+79.6%) | -$161.49 M(+10.6%) |
| Sept 2016 | - | -$146.08 M(+14.5%) |
| June 2016 | - | -$127.58 M(+20.9%) |
| Mar 2016 | - | -$105.49 M(+134.7%) |
| Dec 2015 | -$89.91 M(+34.4%) | - |
| Sept 2015 | - | -$44.94 M(+31.9%) |
| June 2015 | -$66.91 M(+107.4%) | - |
| Dec 2014 | - | -$34.08 M(+5.6%) |
| June 2014 | -$32.26 M(+82.8%) | -$32.26 M |
| June 2013 | -$17.64 M(+82.6%) | - |
| June 2012 | -$9.66 M | - |
FAQ
- What is Adaptimmune Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual retained earnings year-on-year change?
- What is Adaptimmune Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly retained earnings year-on-year change?
What is Adaptimmune Therapeutics annual retained earnings?
The current annual retained earnings of ADAP is -$1.02 B
What is the all time high annual retained earnings for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual retained earnings is -$9.66 M
What is Adaptimmune Therapeutics annual retained earnings year-on-year change?
Over the past year, ADAP annual retained earnings has changed by -$113.87 M (-12.52%)
What is Adaptimmune Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ADAP is -$1.02 B
What is the all time high quarterly retained earnings for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly retained earnings is -$32.26 M
What is Adaptimmune Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ADAP quarterly retained earnings has changed by -$44.52 M (-4.56%)